Shares of ValiRx plc (LON:VAL – Get Free Report) were up 14.3% during trading on Thursday. The company traded as high as GBX 0.18 and last traded at GBX 0.16. 66,396,219 shares changed hands during mid-day trading, an increase of 425% from the average session volume of 12,638,085 shares. The stock had previously closed at GBX 0.14.
ValiRx Stock Up 14.3%
The business’s 50 day simple moving average is GBX 0.14 and its 200-day simple moving average is GBX 0.23. The stock has a market capitalization of £2.11 million, a price-to-earnings ratio of -0.39 and a beta of 0.59.
ValiRx (LON:VAL – Get Free Report) last announced its quarterly earnings results on Tuesday, September 15th. The company reported GBX (0.09) EPS for the quarter. ValiRx had a negative net margin of 6,548.06% and a negative return on equity of 71.49%. On average, analysts expect that ValiRx plc will post -1.74 earnings per share for the current year.
About ValiRx
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
See Also
- Five stocks we like better than ValiRx
- GE Vernova’s Reservations Are Turning Into Real Orders—But the Market Still Wants More.
- Where’s the Beef? Trian-Led Buyout Proposal Values Wendy’s at $1.4B, But Is It Enough?
- Constellation Energy’s Nuclear Expansion Gets a $5 Billion Opening, Not a Guarantee
- Plugging In: Vertiv Cashes In On AI Demand
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
